Jenny L. Soiffer , Alexander J. Fife , Shrikanth S. Gadad , Javier A. Laurini , Julia A. Elvin , Sara S. Isani , Ken Y. Lin
{"title":"一例ESR1基因扩增的复发性子宫癌肉瘤患者对pembrolizumab、来伐替尼和来曲唑产生了持久的部分应答","authors":"Jenny L. Soiffer , Alexander J. Fife , Shrikanth S. Gadad , Javier A. Laurini , Julia A. Elvin , Sara S. Isani , Ken Y. Lin","doi":"10.1016/j.gore.2024.101426","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":12873,"journal":{"name":"Gynecologic Oncology Reports","volume":null,"pages":null},"PeriodicalIF":1.2000,"publicationDate":"2024-05-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S235257892400105X/pdfft?md5=e968a33e486598435e7f59c3afc3db55&pid=1-s2.0-S235257892400105X-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Durable partial response to pembrolizumab, lenvatinib, and letrozole in a case of recurrent uterine carcinosarcoma with ESR1 gene amplification\",\"authors\":\"Jenny L. Soiffer , Alexander J. Fife , Shrikanth S. Gadad , Javier A. Laurini , Julia A. Elvin , Sara S. Isani , Ken Y. Lin\",\"doi\":\"10.1016/j.gore.2024.101426\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":12873,\"journal\":{\"name\":\"Gynecologic Oncology Reports\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.2000,\"publicationDate\":\"2024-05-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S235257892400105X/pdfft?md5=e968a33e486598435e7f59c3afc3db55&pid=1-s2.0-S235257892400105X-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Gynecologic Oncology Reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S235257892400105X\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"OBSTETRICS & GYNECOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gynecologic Oncology Reports","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S235257892400105X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
期刊介绍:
Gynecologic Oncology Reports is an online-only, open access journal devoted to the rapid publication of narrative review articles, survey articles, case reports, case series, letters to the editor regarding previously published manuscripts and other short communications in the field of gynecologic oncology. The journal will consider papers that concern tumors of the female reproductive tract, with originality, quality, and clarity the chief criteria of acceptance.